Monthly Asthma Jab Could Transform Lives
A new monthly injection, Tezepelumab, enabled 90% of severe asthma patients to reduce daily steroids in a major UK trial. Discover this life-changing treatment.
Category : Pharmaceuticals
Asthma breakthrough: Monthly injection cuts steroid use
Groundbreaking UK-led trial reveals a monthly injection allows severe asthma patients to stop or drastically reduce steroid medication, transforming treatment options.
Simon Curtis reveals incredible 225lbs weight loss
Former Nickelodeon star Simon Curtis unveils his dramatic body transformation, shedding 225lbs with peptide therapy. Discover his fitness journey and the science behind his new look.
15 Drugs Including Ozempic Get Price Cuts
The Trump administration announces reduced Medicare prices for 15 prescription drugs, including Ozempic and cancer treatments, set to save $12 billion. Learn more about the new healthcare policy.
My Winter Cold Cure: Elizabeth Arden's Cream Saved Me
Discover how a beauty cult classic, Elizabeth Arden's Eight Hour Cream, became an unexpected hero during a brutal winter cold, offering instant relief for sore, red skin. Read the full review.
Australia restricts high-dose vitamin B6 supplements
Australia's drug regulator is moving high-dose vitamin B6 supplements behind pharmacy counters from 2027 after hundreds of nerve damage reports. Learn the risks and what to do now.
ByHeart Formula: All Lots May Contain Botulism
Tests reveal ByHeart infant formula from all lots may be contaminated with botulism bacteria. Dozens of babies sickened. Parents urged to stop use immediately and check for symptoms.
Walgreens Nasal Spray Recall Over Bacteria Risk
Walgreens recalls over 41,000 saline nasal sprays contaminated with Pseudomonas lactis. The FDA warns consumers to stop use immediately due to potential health risks for immunocompromised individuals.
Mounjaro weight regain study reveals health reversal
New UK research finds stopping Mounjaro leads to significant weight regain and reverses health benefits. Discover why long-term obesity treatment is crucial.
The Ordinary's New Serum: A Beauty Editor's Verdict
Beauty editor Sabine Wiesel tests The Ordinary's new volufiline serum, dubbed 'filler in a bottle', to see if it delivers a more youthful look in your 40s. Discover the results.
Novo Nordisk Alzheimer's trial fails, shares drop
Novo Nordisk's Rybelsus fails to slow Alzheimer's cognitive decline in major trial, causing a 10% share price drop. Read the full analysis of this pharmaceutical setback.
New Medical Uses for Weight-Loss Drugs Revealed
Explore how drugs like Ozempic and Wegovy are being tested for conditions from Alzheimer's to sleep apnea, despite a recent trial setback. Discover the future of GLP-1 treatments.
Novo Nordisk Alzheimer's drug trial fails
A major study testing Novo Nordisk's semaglutide for Alzheimer's disease has failed, dealing a blow to hopes of a new treatment for over 55 million patients. Discover the full story.
Novo Nordisk shares drop after Ozempic fails Alzheimer's test
Novo Nordisk shares slumped over 10% after its Ozempic pill failed to slow Alzheimer's progression in major trials. Discover the implications for the pharmaceutical giant's market position.
Novo Nordisk Alzheimer's Drug Trial Fails
Novo Nordisk's major Alzheimer's drug trial fails to show significant benefit, dashing hopes for a fast-tracked treatment. Read the full analysis of this setback.
John Lewis: Buprenorphine Pioneer Dies Aged 92
Discover how chemist John Lewis helped develop buprenorphine, a life-saving treatment for opioid addiction used by millions worldwide. Learn about his remarkable legacy.
Gemma Collins resumes Mounjaro with microdosing plan
TOWIE star Gemma Collins reveals she is microdosing weight loss jab Mounjaro after a health scare. She has lost 3.5st and aims for 6st total. Discover her new approach.
Saffron's hidden health benefits for brain and body
Discover how saffron, the world's most expensive spice, may help treat depression, Alzheimer's symptoms, and improve heart and eye health. Explore the science behind 'Red Gold'.
Daily Weight Loss Pill Cheaper Than Injections
New once-daily pill orforglipron could help people lose up to 10% body weight at lower cost than current weight loss jabs used by 2.5 million Britons.
Ozempic's Impact on Thanksgiving Dinner Traditions
As 12% of US adults use GLP-1 drugs like Ozempic, Thanksgiving dinners are transforming. Discover how appetite suppression is changing holiday dynamics and etiquette.
UK Prescription Crisis: 7 Risky Medications
Leading pharmacist warns millions face medication dependency. Discover the 7 common prescription drugs with devastating side effects and safer alternatives you must discuss with your GP.
Prozac no better than placebo for children
New research reveals Prozac offers no clinical benefit over placebo for childhood depression, prompting calls for urgent changes to UK treatment guidelines.
New Daily Weight Loss Pill Cheaper Than Injections
A new once-a-day weight loss pill, orforglipron, could offer wider access to treatment. The study confirms it helps shed up to 9.6% of body weight and will be cheaper than jabs.
New Weight Loss Pill Shows 9.6% Reduction in Trial
A new daily pill from Lilly promises significant weight loss and blood sugar control, offering a needle-free alternative to injections. Could this revolutionise obesity treatment in the UK?
Weight Loss Jabs: 173 UK Deaths Linked to Drugs
Leading doctors warn of life-threatening side effects from popular weight loss drugs like Ozempic. Discover the hidden dangers and who should avoid these 'miracle' jabs.
New TB drug shows breakthrough potential in trial
Sorfequiline, a new antibiotic, demonstrates stronger action against tuberculosis with potential to revolutionise treatment. Could this be the breakthrough against the killer disease?
ABC Director Defends Broadcaster, Concedes Bluey Mistake
ABC Managing Director Hugh Marks defends the broadcaster against 'false' criticism while admitting a major financial misstep with the global hit Bluey. Discover the full story.
New Pill May Slash Breast Cancer Recurrence Risk
A groundbreaking new pill from Roche shows promise in significantly reducing the risk of deadly breast cancer returning after treatment, offering new hope for thousands of patients.
Sacklers to pay $7bn in opioid crisis settlement
A federal judge approves a $7bn settlement from the Sackler family over the opioid crisis. The deal directs funds to combat the epidemic and compensate victims. Discover the full implications.
Judge approves $7bn Purdue Pharma opioid settlement
A US judge is set to explain his approval of Purdue Pharma's opioid settlement, compelling the Sackler family to pay $7bn. Victims to receive compensation from 2025. Read the full details.
Page 2 of 11